LPL Financial’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$587K Buy
+5,166
New +$587K ﹤0.01% 4186
2024
Q4
Sell
-3,075
Closed -$308K 5231
2024
Q3
$308K Buy
3,075
+119
+4% +$11.9K ﹤0.01% 4327
2024
Q2
$249K Buy
+2,956
New +$249K ﹤0.01% 4318
2022
Q4
Sell
-6,006
Closed -$323K 4481
2022
Q3
$323K Buy
6,006
+934
+18% +$50.2K ﹤0.01% 3503
2022
Q2
$282K Buy
5,072
+568
+13% +$31.6K ﹤0.01% 3653
2022
Q1
$316K Sell
4,504
-587
-12% -$41.2K ﹤0.01% 3526
2021
Q4
$491K Buy
5,091
+229
+5% +$22.1K ﹤0.01% 3286
2021
Q3
$423K Buy
4,862
+426
+10% +$37.1K ﹤0.01% 3355
2021
Q2
$363K Buy
4,436
+151
+4% +$12.4K ﹤0.01% 3423
2021
Q1
$407K Buy
+4,285
New +$407K ﹤0.01% 3192
2020
Q1
Sell
-3,092
Closed -$201K 3323
2019
Q4
$201K Sell
3,092
-411
-12% -$26.7K ﹤0.01% 3084
2019
Q3
$217K Buy
+3,503
New +$217K ﹤0.01% 2922
2019
Q1
Sell
-3,921
Closed -$332K 3199
2018
Q4
$332K Sell
3,921
-9,224
-70% -$781K ﹤0.01% 2378
2018
Q3
$2.25M Buy
13,145
+7,929
+152% +$1.36M 0.01% 1100
2018
Q2
$674K Buy
+5,216
New +$674K ﹤0.01% 1927
2018
Q1
Sell
-6,537
Closed -$558K 3201
2017
Q4
$558K Sell
6,537
-255
-4% -$21.8K ﹤0.01% 1954
2017
Q3
$577K Buy
6,792
+382
+6% +$32.5K ﹤0.01% 1832
2017
Q2
$485K Sell
6,410
-2,273
-26% -$172K ﹤0.01% 1897
2017
Q1
$572K Buy
8,683
+1,407
+19% +$92.7K ﹤0.01% 1684
2016
Q4
$465K Buy
7,276
+1,149
+19% +$73.4K ﹤0.01% 1806
2016
Q3
$384K Sell
6,127
-121
-2% -$7.58K ﹤0.01% 1936
2016
Q2
$482K Buy
6,248
+2,359
+61% +$182K ﹤0.01% 1709
2016
Q1
$269K Buy
+3,889
New +$269K ﹤0.01% 2597
2015
Q1
Sell
-26,036
Closed -$864K 2833
2014
Q4
$864K Buy
+26,036
New +$864K ﹤0.01% 1412